Synthesis, cytotoxicity, and DNA-binding levels of ammine/cyclohexylamine platinum(II) complexes with dicarboxylates

被引:10
作者
Zhang, JC [1 ]
Yong, S [1 ]
机构
[1] Hebei Univ, Coll Chem & Environm Sci, Dept Chem, Baoding 071002, Peoples R China
关键词
ammine/cyclohexylamine platinum(II) complexes; synthesis; cytotoxicity; cell cycle; DNA binding;
D O I
10.1080/15533170600651462
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Four new ammine/cyclohexylamine platinum(II) complexes with dicarboxylates (a-d) have been synthesized and characterized by elemental analysis, conductivity, IR, UV, and (HNMR)-H-1 spectra techniques. The cytotoxicity of the complexes was tested by MTT assay. The cell cycle analysis and the levels of total platinum bound to DNA were measured by flow cytometry and ICP-MS. The results show that the cytotoxicity of complexes (a-d) against EJ, HCT-8, BGC-823, HL-60, and MCF-7 cell lines decreases in the sequence: b>a>c>d. Complexes (a-d) have better cytotoxicity against EJ and HL-60 and complex (b) demonstrates cytotoxicity superior to that of the clinically established cisplatin. The complexes (a-d) induced a concentration-dependent accumulation of HL-60 cells in the G(2)/M phase of the cell cycle as cisplatin. The levels of total platinum bound to DNA in HL-60 and EJ cells decrease in the sequence: b>cisplatin>a>c>d under the same experimental conditions.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 27 条
[1]  
Boulikas T, 2003, ONCOL REP, V10, P1663
[2]   RELATIONSHIPS BETWEEN THE CARBON-OXYGEN STRETCHING FREQUENCIES OF CARBOXYLATO COMPLEXES AND THE TYPE OF CARBOXYLATE COORDINATION [J].
DEACON, GB ;
PHILLIPS, RJ .
COORDINATION CHEMISTRY REVIEWS, 1980, 33 (03) :227-250
[3]   NONCLASSICAL PLATINUM ANTITUMOR AGENTS - PERSPECTIVES FOR DESIGN AND DEVELOPMENT OF NEW DRUGS COMPLEMENTARY TO CISPLATIN [J].
FARRELL, N .
CANCER INVESTIGATION, 1993, 11 (05) :578-589
[4]  
Ferlini C, 1996, CYTOMETRY, V24, P106
[5]   Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA [J].
Gourdier, I ;
Crabbe, L ;
Andreau, K ;
Pau, B ;
Kroemer, G .
ONCOGENE, 2004, 23 (45) :7449-7457
[6]  
Greary WJ, 1971, COORDIN CHEM REV, V7, P81
[7]   The influence of structure on the activity and toxicity of Pt anti-cancer drugs [J].
Hambley, TW .
COORDINATION CHEMISTRY REVIEWS, 1997, 166 :181-223
[8]   Platinum-based anticancer agents: Innovative design strategies and biological perspectives [J].
Ho, YP ;
Au-Yeung, SCF ;
To, KKW .
MEDICINAL RESEARCH REVIEWS, 2003, 23 (05) :633-655
[9]   Tumour-inhibiting platinum complexes-state of the art and future perspectives [J].
Jakupec, MA ;
Galanski, M ;
Keppler, BK .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 :1-53
[10]  
KELLAND LR, 1992, CANCER RES, V52, P822